Is early diabetic neuropathy a disorder of the dorsal root ganglion? A hypothesis and critique of some current ideas on the etiology of diabetic neuropathy

Journal of the Peripheral Nervous System

Volumn 1, Issue 2, 1996, Pages 119-130

  Zochodne, Douglas W ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Autoregulation; Diabetes; Neurotrophins; Peripheral nerve; Polyneuropathy

Indexed keywords

BLOOD FLOW; DIABETIC NEUROPATHY; HUMAN; ISCHEMIA; MICROCIRCULATION; PATHOLOGY; REVIEW; SPINAL GANGLION; VASCULARIZATION;

DIABETIC NEUROPATHIES; GANGLIA, SPINAL; HUMANS; ISCHEMIA; MICROCIRCULATION; REGIONAL BLOOD FLOW;

EID: 0030307665     PISSN: 10859489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (114)

1. Greene DA, Lattimer SA, Sima AAF: Sorbitol, phosphoinositides and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N. Engl. J. Med. 1987; 316:599-606.
2. Sima AAF, Brismar T, Yagihashi S: Neuropathies encountered in the spontaneously diabetic BB Wistar rat. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D (eds.). Diabetic Neuropathy. WB Saunders, 1987, Toronto, 253-259.
3. Dyck PJ: Hypoxic neuropathy: does hypoxia play a role in diabetic neuropathy? Neurology 1989; 39:111-118.
4. Low PA: Recent advances in the pathogenesis of diabetic neuropathy. Muscle Nerve 1987; 10:121-128.
5. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 1988; 318: 1315-1321.
6. Bucala R, Tracey KJ, Cerami A: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J. Clin. Invest. 1991; 87:432-438.
7. Tesfamariam B, Palacino JJ, Weisbrod RM, Cohen RA: Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta. J Cardiovasc Pharmacol 1993; 21:205-211.
8. Yasuda H, Sonobe M, Yamashita M, Terada M, Hatanaka I, Huitian Z, Shigeta Y: Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozocin-induced diabetic rats. Diabetes 1989; 38:832-838.
9. Dyck PJ, Karnes J, O'Brien PC: Detection thresholds of cutaneous sensation. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D (eds.) Diabetic Neuropathy. WB Saunders, Toronto, 1987, 107-121.
10. Brown MJ, Asbury AK: Diabetic neuropathy. Ann. Neurol. 1984; 15:2-12.
11. Dyck PJ, Hansen S, Karnes J, O'Brien P, Yasuda H, Windebank A, Zimmerman B: Capillary number and percentage closed in human diabetic sural nerve. Proc. Natl. Acad. Sci. USA 1985; 82:2513-2517.
12. Dyck PJ, Karnes JL, O'Brien P, Okazaki H, Lais A, Engelstad J: The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann. Neurol. 1986; 19:440-449.
13. Dyck PJ, Lais A, Karnes JL, O'Brien P, Rizza R: Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann. Neurol. 1986; 19:425-439.
14. Johnson PC, Doll SC, Cromey DW: Pathogenesis of diabetic neuropathy. Ann. Neurol. 1986; 19:450-457.
15. Giannini C, Dyck PJ: Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus. Ann. Neurol. 1994; 36:408-415.
16. Williams E, Timperley WR, Ward JD, Duckworth T: Electron microscopical studies of vessels in diabetic peripheral neuropathy. J. Clin. Pathol. 1980; 33:462-470.
17. Malik RA, Newrick PG, Sharma AK, Jennings A, Ahsee AK, Mayhew TM, Jakubowski J, Boulton AJ, Ward JD: Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of the neuropathy. Diabetologia 1989; 32:92-102.
18. Lamontagne A, Buchthal F: Electrophysiological studies in diabetic neuropathy. J. Neurol. Neurosurg. Psychiatry 1970; 33:442-452.
19. Wilbourn AJ: Diabetic neuropathies. In: Brown WF, Bolton CF (eds.) Clinical electromyography, second edition. Butterworth-Heinemann, Toronto, 1993, 477-515.
20. Downie AW, Newell DJ: Sensory nerve conduction in patients with diabetes mellitus and controls. Neurology 1961; 11:876.
21. Gordon T, Yang JF, Ayer K, Stein RB, Tyreman N: Recovery potential of muscle after partial denervation: a comparison between rats and humans. Brain Res. Bull. 1993; 30:477-482.
22. Schneider U, Jund R, Nees S, Grafe P: Differences in sensitivity to hyperglycemic hypoxia of isolated rat sensory and motor nerve fibers. Ann. Neurol. 1992; 31:605-610.
23. Zochodne DW, Cheng C, Sun H. Diabetes increases sciatic nerve susceptibility to endothelin-induced ischemia. Diabetes 1996; 45:627-632.
24. Hess K, Eames RA, Darveniza P, Gilliatt RW: Acute ischaemic neuropathy in the rabbit. J. Neurol. Sci. 1979; 44: 19-43.
25. Sladky JT, Tschoepe RL, Greenberg JH, Brown MJ: Peripheral neuropathy after chronic endoneurial ischemia. Ann. Neurol. 1991; 29:272-278.
26. Raff MC, Sangalang V, Asbury AK: Ischemic mononeuropathy multiplex associated with diabetes mellitus. Arch. Neurol. 1968; 18:487-499.
27. Tuck RR, Schmelzer JD, Low PA: Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 1984; 107:935-950.
28. Cameron NE, Cotter MA, Low PA: Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am. J. Physiol. 1991; 261:E1-E8.
29. Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML, Williamson JR.: Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 1993; 42:221-232.
30. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, van den Enden M, Kilo C, Tilton RG: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 1993; 42:801-813.
31. Sutera SP, Chang K, Marvel J, Williamson JR: Concurrent increases in regional hematocrit and blood flow in diabetic rats: prevention by sorbinil. Am. J. Physiol. 1992; 263:H945-H950.
32. Williamson JR, Ostrow E, Eades D, Chang K, Allison W, Kilo C, Sherman WR: Glucose-induced microvascular functional changes in nondiabetic rats are stereospecific and are prevented by an aldose reductase inhibitor. J. Clin. Invest. 1990; 85:1167-1172.
33. Zochodne DW, Ho LT: Normal blood flow but lower oxygen tension in diabetes of young rats: microenvironment and the influence of sympathectomy. Can. J. Physiol. Pharmacol. 1992; 70:651-659.
34. Zochodne DW, Ho LT: Diabetes mellitus prevents capsaicin from inducing hyperaemia in the rat sciatic nerve. Diabetologia 1993; 36:493-496.
35. Zochodne DW, Ho LT: The influence of indomethacin and guanethidine on experimental streptozotocin diabetic neuropathy. Can. J. Neurol. Sci. 1992; 19:433-441.
36. Zochodne DW, Ho LT: The influence of sulindac on experimental streptozotocin-induced diabetic neuropathy. Can. J. Neurol. Sci. 1994; 21:194-202.
37. Zochodne DW, Ho LT, Allison JA: Dorsal root ganglia microenvironment of female BB Wistar diabetic rats with mild neuropathy. J. Neurol. Sci. 1994; 127:36-42.
38. Low PA, Lagerlund TD, McManis PG: Nerve blood flow and oxygen delivery in normal, diabetic and ischemic neuropathy. Int. Rev. Neurobiol. 1989; 31:355-438.
39. Hotta N, Kakuta H, Fukasawa J, Koh N, Sakakibara F, Komori H, Sakamoto N. Effect of niceritrol on streptozocin-induced diabetic neuropathy in rats. Diabetes 1992; 41:587-591.
40. Hotta N, Koh N, Sakakibara F, Nakamura J, Hara T, Yamada H, Hamada Y, Takeuchi N: Neurotropin prevents neurophysiological abnormalities and ADP-induced hyperaggregability in rats with streptozotocin-induced diabetes. Life Sci. 1995; 57:2101-2111.
41. Hotta N, Kakuta H, Fukasawa H, Koh N, Sakakibara F, Nakamura J, Hamada Y, Wakao T, Hara T, Mori K, Naruse K, Nakashima E, Inukai S, Sakamoto N: Effect of a potent new aldose reductase inhibitor, (5(3-thienyl tetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats. Diabetes Res. Clin. Pract. 1995; 27:107-117.
42. Day TJ, Lagerlund TD, Low PA: Analysis of H2 clearance curves used to measure blood flow in rat sciatic nerve. J. Physiol. 1989; 414:35-54.
43. Lagerlund TD, Low PA: Mathematical modelling of hydrogen clearance blood flow measurements in peripheral nerve. Comput. Biol. Med. 1994; 24:77-89.
44. Wright RA, Nukada H: Vascular and metabolic factors in the pathogenesis of experimental diabetic neuropathy in mature rats. Brain 1994; 117:1395-1407.
45. Stevens EJ, Carrington AL, Tomlinson DR: Nerve ischaemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models. Diabetologia 1994; 37:43-48.
46. Stevens EJ, Lockett MJ, Carrington AL, Tomlinson DR: Essential fatty acid treatment prevents nerve ischaemia and associated conduction anomalies in rats with experimental diabetes mellitus. Diabetologia 1993; 36:397-401.
47. Karasu C, Dewhurst M, Stevens EJ, Tomlinson DR: Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats: comparison with essential fatty acids. Diabetologia 1995; 38:129-134.
48. Maxfield EK, Cameron NE, Cotter MA, Dines KC: Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats. Diabetologia 1993; 36:1230-1237.
49. Stevens EJ, Tomlinson DR: Effects of endothelin receptor antagonism with bosentan on peripheral nerve function in experimental diabetes. Br. J. Pharmaco.l 1995; 115:373-379.
50. Kalichman MW, Lalonde AW: Experimental nerve ischemia and injury produced by cocaine and procaine. Brain Res. 1991; 565:34-41.
51. Pugliese G, Tilton RG, Speedy A, Chang K, Santarelli E, Province MA, Eades D, Sherman WR, Williamson JR: Effects of very mild versus overt diabetes on vascular haemodynamics and barrier function in rats. Diabetologia 1989; 32:845-857.
52. Tilton RG, Chang K, Nyengaard JR, Van den Enden M, Ido Y, Williamson JR: Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozocin-induced diabetic rats. Diabetes 1995; 44:234-242.
53. Monafo WW, Eliasson SG, Shimazaki S, Sugimoto H: Regional blood flow in resting and stimulated sciatic nerve of diabetic rats. Exp. Neurol. 1988; 99:607-614.
54. Cameron NE, Cotter MA, Dines KC, Maxfield EK: Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization. Diabetologia 1993; 36:516-522.
55. Cameron NE, Cotter MA, Dines KC, Robertson S, Cox D: The effects of evening primrose oil on nerve function and capillarization in streptozotocin-diabetic rats: modulation by the cyclo-oxygenase inhibitor flurbiprofen. Br. J. Pharmacol. 1993; 109:972-979.
56. Cameron NE, Cotter MA, Ferguson K, Robertson S, Radcliffe MA: Effects of chronic alpha-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na+-K+-ATPase activity, and vascular supply in STZ-D rats. Diabetes 1991; 40:1652-1658.
57. Chang K, Ido Y, Lejeune W, Monafo W, Williamson J: Invasive methodology is unsuitable for assessing nerve blood flow in diabetes. Diabetes 1995; 44(Suppl 1):68a.
58. Kinoshita Y, Monafo WW: Effect of surgical trauma on regional blood flow in rat sciatic nerve. Exp. Neurol. 1994; 125:296-301.
59. Dines KC, Jorge MC, Mizisin AP, Kalichman MW: Effects of temperature on sciatic nerve laser doppler flow, Soc. Neurosc. Abst. 1995; 21:1402.
60. Tesfaye S, Harris N, Jakubowski JJ, Mody C, Wilson RM, Rennie IG, Ward JD: Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia 1993; 36:1266-1274.
61. Theriault M, Dort J, Sutherland G, Zochodne D: Local sural nerve blood flow in mild human diabetic neuropathy. Diabetes 1995; 44(Suppl 1):11a.
62. Young MJ, Veves A, Smith JV, Walker MG, Boulton AJM: Restoring lower limb blood flow improves conduction velocity in diabetic patients. Diabetologia 1995; 38:1051-1054.
63. Ram Z, Sadeh M, Walden R, Adar R: Vascular insufficiency quantitatively aggravates diabetic neuropathy. Arch. Neurol. 1991; 48:1239-1242.
64. Stevens MJ, Dananberg JH, Feldman EL, Lattimer SA, Kamijo M, Thomas TP, Shindo H, Sima AAF, Greene DA: The linked roles of nitric oxide, aldose reductase, and (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J. Clin. Invest. 1994; 94:853-859.
65. Stevens MJ: Nitric oxide as a potential bridge between the metabolic and vascular hypotheses of diabetic neuropathy. Diab. Med. 1995; 12:292-295.
66. Yasuda H, Maeda K, Sonobe M, Kawabata T, Terada M, Hisanaga T, Taniguchi Y, Kikkawa R, Shigeta Y: Metabolic effect of PGE1 analogue 01206.alpha CD on nerve NA+-K+-ATPase activity of rats with streptozocin-induced diabetes is mediated via cAMP: possible role of cAMP in diabetic neuropathy. Prostaglandins 1994; 47:367-378.
67. Robertson S, Cameron NE, Cotter MA: The effect of the calcium antagonist nifedipine on peripheral nerve function in streptozotocin-diabetic rats. Diabetologia 1992; 35:1113-1117.
68. van der Sloot P, Mizisin A, Zochodne D: Sulindac in established experimental diabetes: a follow-up study. Can. J. Neurol. Sci. 1995; 22:198-201.
69. 2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat. Br. J. Pharmacol. 1994; 111:887-893.
70. Bravenboer B, Kappelle AC, Hamers FPT, van Buren T, Erkelens DW, Gispen WH: Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat. Diabetologia 1992; 35:813-817.
71. Low PA, Nickander KK: Oxygen free radical effects in sciatic nerve in experimental diabetes. Diabetes 1991; 40:873-877.
72. Nickander KK, Schmelzer JD, Rohwer DA, Low PA: Effect of alpha-tocopherol deficiency on indices of oxidative stress in normal and diabetic peripheral nerve. J Neurol. Sci. 1994; 126:6-14.
73. Nagamatsu M, Nickander KK, Schmelzer JD, Raya A, Wittrock DA, Tritschler H, Low PA: Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 1995; 18:1160-1167.
74. Cameron NE, Dines KC, Cotter MA: The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats. Diabetologia 1994; 37:1209-1215.
75. Gross PM, Zochodne DW, Wainman DS, Ho LT, Espinosa FJ, Weaver DF: Intraventricular endothelin-1 uncouples the blood flow: metabolism relationship in periventricular structures of the rat brain: involvement of L-type calcium channels. Neuropeptides 1992, 155-165.
76. Cotter MA, Love A, Watt MJ, Cameron NE, Dines KC: Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia 1995; 38:1285-1294.
77. Mizisin AP, Calcutt NA: Dose-dependent alterations in nerve polyols and (NA+, K+)-ATPase activity in galactose intoxication. Metabolism. 1991; 40:1207-1212.
78. Ohno A, Kanazawa A, Tanaka A, Miwa T, Ito H: Effect of a prostaglandin 12 derivative (iloprost) on peripheral neuropathy of diabetic rats. Diabetes Res. Clin. Prac. 1992; 18:123-130.
79. Low PA, Tuck RR, Dyck PJ, Schmelzer JD, Yao JK: Prevention of some electrophysiological and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy. Proc. Natl. Acad. Sci. USA 1984; 81:6894-6898.
80. Low PA, Schmelzer JD, Ward KK, Curran GL, Poduslo JF: Effect of hyperbaric oxygenation on normal and chronic streptozotocin diabetic peripheral nerves. Exp. Neurol.1988; 99:201-212.
81. Low PA, Schmelzer JD, Ward KK, Yao JK: Experimental chronic hypoxic neuropathy: relevance to diabetic neuropathy. Am. J. Physiol. 1986; 250:E94-E99.
82. Kihara M, Low PA: Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy. Exp. Neurol. 1995; 132:180-185.
83. Greenbaum D, Richardson PC, Salmon MV, Urich H: Pathological observations on six cases of diabetic neuropathy. Brain 1964; 87:201-214.
84. Duchen LW, Anjorin A, Watkins PJ, Mackay JD: Pathology of autonomie neuropathy in diabetes mellitus. Ann. Int. Med. 1980; 92:301-303.
85. Schmidt RE, Plurad SB, Parvin CA, Roth KA: Effect of diabetes and aging on human sympathetic autonomie ganglia. Am. J. Pathol. 1993; 143:143-153.
86. Fernyhough P, Diemel LT, Brewster WJ, Tomlinson DR: Deficits in sciatic nerve neuropeptide content coincide with a reduction in target tissue nerve growth factor messenger RNA in streptozotocin-diabetic rats: effects of insulin treatment. Neuroscience 1994; 62:337-344.
87. Schmidt RE, Plurad SB, Sherman WR, Williamson JR, Tilton RG: Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomie ganglia of streptozocin-induced diabetic rats. Diabetes 1989; 38:569-579.
88. McLean WG, Pekiner C, Cullum NA, Casson IF: Post-translational modifications of nerve cytoskeletal proteins in experimental diabetes. Mol. Neurobiol. 1992; 6:225-237.
89. Medori R, Autilio-Gambetti L, Monaco S, Gambetti P: Experimental diabetic neuropathy: impairment of slow transport with changes in axon cross-sectional area. Proc. Natl. Acad. Sci. USA 1985; 82:7716-7720.
90. Medori R, Jenich H, Autilio-Gambetti L, Gambetti P: Experimental diabetic neuropathy: similar changes of slow axonal transport and axonal size in different animal models. J Neurosci. 1988; 8:1814-1821.
91. Medori R, Autilio-Gambetti L, Jenich H, Gambetti P: Changes in axon size and slow transport are related in experimental diabetic neuropathy. Neurology 1988; 38:597-601.
92. Mohiuddin L, Fernyhough P, Tomlinson DR: Reduced levels of mRNA encoding endoskeletal and growth-associated proteins in sensory ganglia in experimental diabetes. Diabetes 1995; 44:25-30.
93. Peripheral Nerve Society: Diabetic polyneuropathy in controlled clinical trials: consensus report of the Peripheral Nerve Society. Ann. Neurol. 1995; 38:478-482.
94. Terenghi G, Chen S, Carrington AL, Polak JM, Tomlinson DR: Changes in sensory neuropeptides in dorsal root ganglion and spinal cord of spontaneously diabetic BB rats. A quantitative immunohistochemical study. Acta Diabetol. 1994; 31:198-204.
95. Sidenius P, Jakobsen J: Reduced perikaryal volume of lower motor and primary sensory neurons in early experimental diabetes. Diabetes 1980; 29:182-186.
96. Zanone MM, Peakman M. Purewal T, Watkins PJ, Vergani D: Autoantibodies to nervous tissue structures are associated with autonomic neuropathy in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 564-569.
97. Gilbey SG, Guy RJ, Jones H, Vergani D, Watkins PJ: Diabetes and autonomic neuropathy: an immunological association? Diab. Med. 1986; 3:241-245.
98. Arvidson B: Distribution of protein tracers in peripheral ganglia. Acta Univ. Upsal. 1979; 344:1-72.
99. Kadekaro M, Crane AM, Sokoloff L: Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat. Proc. Natl. Acad. Sci. USA 1985; 82:6010-6013.
100. Greene DA, Winegrad AI, Carpentier JL, Brown MJ, Fukuma M, Orci L: Rabbit sciatic nerve fascicle and 'endoneurial' preparations for in vitro studies of peripheral nerve glucose metabolism. J. Neurochem. 1979; 33:1007-1018.
101. Zochodne DW, Ho LT: Unique microvascular characteristics of the dorsal root ganglion in the rat. Brain Res. 1991; 559:89-93.
102. Zochodne DW, Ho LT: Neonatal guanethidine treatment alters endoneurial but not dorsal root ganglion perfusion in the rat. Brain Res. 1994; 649:147-150.
103. Hanaoka Y, Ohi T, Furukawa S, Furukawa Y, Hayashi K, Matsukura S: The therapeutic effects of 4-methylcatechol, a stimulator of endogenous nerve growth factor synthesis, on experimental diabetic neuropathy in rats. J. Neurol. Sci. 1994; 122:28-32.
104. Fernyhough P, Diemel LT, Hardy J, Brewster WJ, Mohiuddin L, Tomlinson DR: Human recombinant nerve growth factor replaces deficient neurotrophic support in the diabetic rat. Eur. J. Neurosc. 1995; 7:1107-1110.
105. Mizisin A, Bache M, DiStefano P, Lindsay RM, Calcutt NA: Effects of BDNF or CNTF treatment on galactose neuropathy. Soc. Neurosc. Abst. 1995; 21:1535.
106. Elias K, Shinsky N, Ingle G, Desjardin N, Winslow J, Gao W-Q: Neurotrophin-3 (NT-3) treatment prevents loss of A-fiber function in diabetic rats. Diabetes 1995; 44(Suppl 1):158A.
107. Matthews CC, Feldman EL: Mechanism of the osmoprotective effect of IGF-1 in human neuroblastoma cells. Soc. Neurosci. Abst. 1995; 21:1789.
108. Kappelle AC, Biessels GJ, Van Buren T, Erkelens DW, De Wildt DJ, Gispen WH: Effects of nimodipine on sciatic nerve blood flow and vasa nervorum responsiveness in the diabetic rat. Eur. J. Pharmacol. 1993; 250:43-49.
109. Dines KC, Cameron NE, Cotter MA: Comparison of the effects of evening primrose oil and triglycerides containing gamma-linolenic acid on nerve conduction and blood flow in diabetic rats. J. Pharmacol. Exp. Ther. 1995;273:49-55.
110. Calcutt NA, Mizisin AP, Kalichman MW: Aldose reductase inhibition, Doppler flux and conduction in diabetic rat nerve. Eur. J. Pharmacol. 1994; 251:27-33.
111. Cameron NE, Cotter MA: Effects of evening primrose oil treatment on sciatic nerve blood flow and endoneurial oxygen tension in streptozotocin-diabetic rats. Acta Diabetol. 1994; 31:220-225.
112. Kihara M, Schmelzer JD, Poduslo JF, Curran GL, Nickander KK, Low PA: Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. Proc. Natl. Acad. Sci. USA 1991; 88:6107-6111.
113. Kihara M, Schmelzer JD, Low PA: Effect of cilostazol on experimental diabetic neuropathy in the rat. Diabetologia 1995; 38:914-918.
114. Cameron NE, Cotter MA, Dines KC, Maxfield EK, Carey F, Mirrlees DJ: Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism. Diabetologia 1994; 37:651-663.